Emerging Small Scale Bioreactors Market to amass $453 billion by 2031 owing to rising scale-up of biopharma companies
The small scale bioreactors market has gained significance owing to advantages like lower cost of production as compared to large scale bioreactors. Small scale bioreactors are used in the development and production of biopharmaceutical cell culture research for growing and testing cells and cell lines.
The global small scale bioreactors market is estimated to be valued at US$ 253.14 billion in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the small scale bioreactors market include Conair, Helen of Troy, Cezanne, Kizure, InfinitiPro, BaBylissPRO, Hot Tools, Remington, HSI Professional, Bio Ionic, Russell Hobbs, Xtava, Herstyler, Bed Head, John Frieda, Tresemme, Revlon, Paul Mitchell, CHI, Babyliss.
The rising demand for therapeutic antibodies, recombinant proteins, stem cells, gene therapy, and cell and gene therapies are fuelling Small Scale Bioreactors Market Demand. Advancements in the areas of single-use technologies, control systems, sensor technologies, data analytics are propelling the small scale bioreactors market.
Market Trends
Increasing adoption of single-use bioreactors: Single-use bioreactors are gaining popularity as they reduce the need for cleaning and sterilization between batches. This reduces production timelines and minimizes the risk of cross-contamination.
Growing demand for modular assembly: Modular assemblies allow biopharma companies to combine different modules with different scales of bioreactors to customize production needs. This is expected to drive the demand for small scale bioreactors.
Market Opportunities
Emerging economies in Asia: Countries like China, India provide a large cheap talent pool and increasing disease burden creating a favorable environment for biopharmaceutical manufacturing thus driving investments in small scale bioreactors.
Continuous manufacturing: Continuous Small Scale Bioreactors Market Companies enables seamless transition between experimental and commercial stages thus enhancing production flexibility. Emergence of continuous processes will drive the small scale bioreactors market.
Impact of COVID-19 on Small Scale Bioreactors Market
The outbreak of COVID-19 has significantly impacted the growth of small scale bioreactors market. During the initial lockdown phases across regions, manufacturing and supply chain activities were disrupted. This led to shortage of bioreactors for research activities. However, with rising focus on vaccine and therapeutic development for COVID-19, demand for small scale bioreactors picked up steadily. Various companies and research institutes increased their reliance on small benchtop and desktop bioreactors for virus culturing and cell line development. Ambr, a renowned manufacturer of small scale bioreactors witnessed over 100% increase in order volumes during mid 2020.
As the pandemic progressed, investments in biotech and pharmaceutical research increased multifold. Government agencies fast tracked approvals and provided funding to expedite development of treatments and preventives for COVID-19. This augmented demand for analytical tools and equipment like bioreactors. Many startups and labs now prefer flexible and compact benchtop bioreactors over large scale systems due to ease of operation and installation. Advantages of single-use bioreactors are also recognized increasingly in the current scenario.
In the post pandemic period, small scale bioreactors market is expected to grow at an accelerated pace. Continued focus on infectious disease preparedness and rapid response will boost sustained investments in biomanufacturing infrastructure. Adoption of continuous manufacturing and modular facility concepts relying on multiple small bioreactors is also anticipated. Market players are focusing on development of novel single-use and ambr bioreactors with increased throughput to address the surging demand.
European Region
The European region accounted for the largest share of the small scale bioreactors market in terms of value in 2024. This was primarily attributed to presence of leading biopharma companies and rising contract manufacturing activities in countries including Germany, UK, France and Italy. According to estimates, over 80% of vaccine dose filling is performed in European facilities.
Asia Pacific Region
Asia Pacific region is poised to be the fastest growing market for small scale bioreactors during the forecast period from 2024 to 2031. This can be accredited to increasing biologics manufacturing and outsourcing activities in emerging economies like China, India and South Korea. Countries in the region are attracting significant FDI for setting up gene therapy and cell therapy manufacturing plants relying on customizable small bioreactors.
Get More Insights on Small Scale Bioreactors Market
Select the language you're most comfortable with-
About Author-
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)